Loss of Smad3 activity has been shown to yield protection from radiation-induced fibrosis 39, bleomycin-induced pulmonary fibrosis 40 and tubulointerstitial fibrosis in the UUO model 41. Here, SMAD3 is linked to pulmonary fibrosis.